CVS Group (LON:CVSG) Stock Price Breaks Below 200-Day Moving Average - Here's What Happened

Key Points

• CVS Group shares fell below their 200-day moving average, reaching GBX 1,168 before last trading at GBX 1,183, below the GBX 1,226.33 long-term average.
• Analysts maintain a generally positive outlook: four rate the stock “Buy” and two “Hold,” resulting in a consensus “Moderate Buy” rating and an average price target of GBX 1,666.67.
• Recent quarterly EPS was GBX 85.60, while analysts expect full-year EPS of GBX 93.94. Insiders have also bought 3,860 shares over the past 90 days.

CVS Group plc (LON:CVSG - Get Free Report) shares crossed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of GBX 1,226.33 and traded as low as GBX 1,168. CVS Group shares last traded at GBX 1,183, with a volume of 186,123 shares changing hands.

Analyst Ratings Changes

Several equities research analysts recently issued reports on CVSG shares. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a GBX 1,700 price objective on shares of CVS Group in a research report on Monday, July 27th. Shore Capital Group reiterated a "hold" rating and issued a GBX 1,400 target price on shares of CVS Group in a report on Thursday, September 24th. Jefferies Financial Group reiterated a "hold" rating and issued a GBX 1,400 target price on shares of CVS Group in a report on Friday, September 25th. Finally, Berenberg Bank reissued a "buy" rating and issued a GBX 2,000 price target on shares of CVS Group in a research note on Thursday, September 24th. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, CVS Group presently has a consensus rating of "Moderate Buy" and an average target price of GBX 1,666.67.

CVS Group Price Performance

The company has a quick ratio of 0.90, a current ratio of 1.18 and a debt-to-equity ratio of 110.41. The company has a market cap of £798.06 million, a PE ratio of 48.68, a P/E/G ratio of 1.77 and a beta of 1.07. The stock has a 50-day simple moving average of GBX 1,271.20 and a 200 day simple moving average of GBX 1,226.33.

CVS Group (LON:CVSG - Get Free Report) last issued its quarterly earnings data on Thursday, September 24th. The company reported GBX 85.60 earnings per share (EPS) for the quarter. CVS Group had a return on equity of 5.91% and a net margin of 2.43%. Equities analysts expect that CVS Group plc will post 93.94 EPS for the current year.

Insider Buying and Selling at CVS Group

In related news, insider Joanne Shaw purchased 1,592 shares of the company's stock in a transaction on Monday, August 10th. The stock was acquired at an average cost of GBX 1,287 per share, for a total transaction of £20,489.04. Also, insider Robin Alfonso purchased 768 shares of the company's stock in a transaction on Thursday, August 6th. The shares were bought at an average price of GBX 1,294 per share, with a total value of £9,937.92. Insiders have purchased 3,860 shares of company stock valued at $4,956,696 over the last 90 days. 1.48% of the stock is owned by insiders.

CVS Group Company Profile

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy. The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct"). The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.